Alzamend Neuro Inc

ALZN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.94

+$0.05 (+2.65%)

At close: Sep 21, 2026, 4:00 PM ET

$1.90

-$0.04 (-1.93%)

Pre-market: Sep 22, 2026, 8:17 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q1 2027 Jul 30, 2026	Q4 2026 Apr 29, 2026	Q3 2026 Jan 30, 2026	Q2 2026 Oct 30, 2025	Q1 2026 Jul 30, 2025	Q4 2025 Apr 29, 2025	Q3 2025 Jan 30, 2025	Q2 2025 Oct 30, 2024	Q1 2025 Jul 30, 2024	Q4 2024 Apr 29, 2024	Q3 2024 Jan 30, 2024	Q2 2024 Oct 30, 2023	Q1 2024 Jul 30, 2023	Q4 2023 Apr 29, 2023	Q3 2023 Jan 30, 2023	Q2 2023 Oct 30, 2022	Q1 2023 Jul 30, 2022	Q4 2022 Apr 29, 2022	Q3 2022 Jan 30, 2022	Q2 2022 Oct 30, 2021	Q1 2022 Jul 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	27.69K	27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-27.69K	-27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-3.03M	-2.87M	-2.2M	-998.11K	-2.7M	-1.14M	-1.04M	-1.36M	-962.41K	-850.06K	-2.66M	-2.9M	-3.53M	-3.31M	-5.42M	-3.11M	-3.04M	-3.87M	-2.56M	-3.58M	-2.31M
Interest Income	399	1.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3.03M	-2.87M	-2.2M	-1M	-2.7M	-1.14M	-1.04M	-1.36M	-974.41K	-851.53K	-2.66M	-2.91M	-3.53M	-3.31M	-5.43M	-3.11M	-3.04M	-3.87M	-2.57M	-3.6M	-2.32M
Net Income	-3.03M	-2.87M	-2.2M	-1M	-2.7M	-1.14M	-1.04M	-1.36M	-974.41K	-851.53K	-2.66M	-2.91M	-3.53M	-3.31M	-5.43M	-3.11M	-3.04M	-3.87M	-2.57M	-3.6M	-2.32M
Selling & General & Admin	1.94M	2.44M	919.03K	821.83K	959.33K	688.78K	590.3K	1.05M	755.83K	666.64K	751.17K	904.94K	1.16M	1.66M	2.53M	1.57M	1.66M	2.21M	1.68M	1.83M	1.39M
Research & Development	1.09M	434.01K	1.28M	176.28K	1.74M	450.16K	447.11K	311.09K	206.57K	183.43K	1.91M	2M	2.37M	1.65M	2.89M	1.53M	1.38M	1.66M	873.65K	1.75M	916.41K
Other Expenses	-27.69K	-27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3M	2.84M	2.2M	998.11K	2.7M	1.14M	1.04M	1.36M	962.41K	850.06K	2.66M	2.9M	3.53M	3.31M	5.42M	3.11M	3.04M	3.87M	2.56M	3.58M	2.31M
Interest Expense	-2.01K	-13.09K	1.34K	2.65K	2.48K	509	2.02K	3.5K	12.01K	1.47K	2.49K	4.31K	1.84K	519	2.06K	3.59K	1.53K	602	16.3K	16K	13.63K
Selling & Marketing Expenses	n/a	-200K	50K	n/a	150K	3.3K	n/a	304K	40K	n/a	n/a	n/a	247.33K	247.33K	247.33K	247.33K	600	n/a	n/a	600	n/a
Cost & Expenses	3.03M	2.87M	2.2M	998.11K	2.7M	1.14M	1.04M	1.36M	962.41K	850.06K	2.66M	2.9M	3.53M	3.31M	5.42M	3.11M	3.04M	3.87M	2.56M	3.58M	2.31M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.48M	3.34M	3.8M	3.38M	2.11M	468K	613K	377K	85K	76K	78K	72K	72K	71K	72K	72K	72K	65K	69K	69K	62K
Shares Outstanding (Diluted)	4.48M	3.34M	3.8M	3.38M	2.11M	711.27K	613.09K	392.41K	85.31K	76.46K	78.38K	72.93K	72.92K	71.69K	72.83K	72.21K	72.21K	65.13K	69.75K	69.23K	62.66K
EPS (Basic)	-0.68	-0.74	-0.58	-0.30	-1.28	-2.43	-1.70	-3.61	-11.42	-11.14	-33.97	-39.85	-48.38	-46.11	-74.49	-43.07	-42.06	-59.41	-36.89	-52	-37.02
EPS (Diluted)	-0.68	-0.74	-0.58	-0.30	-1.28	-2.43	-1.70	-3.61	-11.42	-11.14	-33.97	-39.85	-48.38	-46.11	-74.49	-43.07	-42.06	-59.41	-36.89	-52	-37.02
EBITDA	-3.03M	-2.95M	-2.17M	-970.42K	-2.67M	-1.13M	-1.02M	-1.35M	-949.72K	-837.38K	-2.65M	-2.89M	-3.51M	-3.3M	-5.42M	-3.1M	-3.03M	-3.87M	-2.56M	-2.3M	-2.31M
EBIT	-3.03M	-2.87M	-2.2M	-998.11K	-2.7M	-1.14M	-1.04M	-1.36M	-962.41K	-850.07K	-2.66M	-2.9M	-3.53M	-3.31M	-5.42M	-3.11M	-3.04M	-3.87M	-2.56M	-3.58M	-2.31M
Depreciation & Amortization	27.69K	-83.06K	27.69K	27.69K	27.69K	12.69K	12.69K	12.69K	12.69K	12.69K	12.69K	12.69K	12.69K	5.32K	5.32K	5.32K	7.1K	3.55K	n/a	1.28M	n/a